Bivalirudin (CAT#: TP-075CL)

Bivalirudin is a synthetic 20 residue peptide (thrombin inhibitor) which reversibly inhibits thrombin. Once bound to the active site, thrombin cannot activate fibrinogen into fibrin, the crucial step in the formation of thrombus. It is administered intravenously. Because it can cause blood stagnation, it is important to monitor changes in hematocrit, activated partial thromboplastin time, international normalized ratio and blood pressure.
This compound belongs to the class of organic compounds known as polypeptides. These are peptides containing ten or more amino acid residues.


  • Datasheet
  • MSDS
  • COA

Specifications

  • Classify
  • Protein therapeutics providing a novel function or activity: Haemostasis and thrombosis
  • Therapeutic
  • Bivalirudin
  • Trade Name
  • Angiomax
  • Function
  • Synthetic hirudin analogue; specifically binds both the catalytic site and the anion-binding exosite of circulating and clot-bound thrombin
  • Examples of clinical use
  • Reduce blood-clotting risk in coronary angioplasty and heparin-induced thrombocytopaenia

References

  • Synonyms
  • Not Available

Downloads

Download resources about recombinant antibody development and antibody engineering to boost your research.

Customer Reviews and Q&As

Submit a review or a question
There are currently no Customer reviews or questions for TP-075CL. Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.

For Research Use Only. Not For Clinical Use.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

© 2024 Creative Biolabs.
  • 0
  • 0
Cart

    Go to compare